Pages that link to "Q41927305"

The following pages link to Cátia Teixeira (Q41927305):

Displaying 31 items.

• Striking HIV-1 Entry by Targeting HIV-1 gp41. But, Where Should We Target? (Q35898024) (← links)
• Design, synthesis, and biological evaluation of N-carboxyphenylpyrrole derivatives as potent HIV fusion inhibitors targeting gp41 (Q37130524) (← links)
• N-cinnamoylated aminoquinolines as promising antileishmanial agents. (Q37263882) (← links)
• Viral surface glycoproteins, gp120 and gp41, as potential drug targets against HIV-1: brief overview one quarter of a century past the approval of zidovudine, the first anti-retroviral drug. (Q37846297) (← links)
• Falcipains, Plasmodium falciparum cysteine proteases as key drug targets against malaria. (Q37856319) (← links)
• Development of Plasmodium falciparum protease inhibitors in the past decade (2002-2012). (Q38091532) (← links)
• A Quinacrine Analogue Selective Against Gastric Cancer Cells: Insight from Biochemical and Biophysical Studies (Q38730329) (← links)
• N-Cinnamoylation of Antimalarial Classics: Effects of Using Acyl Groups Other than Cinnamoyl toward Dual-Stage Antimalarials (Q39027105) (← links)
• N-cinnamoylation of antimalarial classics: quinacrine analogues with decreased toxicity and dual-stage activity (Q39029426) (← links)
• Recycling antimalarial leads for cancer: Antiproliferative properties of N-cinnamoyl chloroquine analogues (Q39067760) (← links)
• In vitro efficiency of 9-(N-cinnamoylbutyl)aminoacridines against blood- and liver-stage malaria parasites (Q39216339) (← links)
• ImmunoPEGliposomes for the targeted delivery of novel lipophilic drugs to red blood cells in a falciparum malaria murine model (Q39260886) (← links)
• Toward the discovery of inhibitors of babesipain-1, a Babesia bigemina cysteine protease: in vitro evaluation, homology modeling and molecular docking studies (Q39331916) (← links)
• Molecular docking and 3D-quantitative structure activity relationship analyses of peptidyl vinyl sulfones: Plasmodium Falciparum cysteine proteases inhibitors. (Q39725235) (← links)
• Effects of novel triple-stage antimalarial ionic liquids on lipid membrane models (Q40124524) (← links)
• N-cinnamoylated chloroquine analogues as dual-stage antimalarial leads (Q41927247) (← links)
• Cinnamic acid/chloroquinoline conjugates as potent agents against chloroquine-resistant Plasmodium falciparum (Q41929063) (← links)
• Novel cinnamic acid/4-aminoquinoline conjugates bearing non-proteinogenic amino acids: towards the development of potential dual action antimalarials (Q42717620) (← links)
• Is the conformational flexibility of piperazine derivatives important to inhibit HIV-1 replication? (Q44483574) (← links)
• Molecular modeling studies of N-substituted pyrrole derivatives--potential HIV-1 gp41 inhibitors (Q46786660) (← links)
• Florent Barbault (Q46786862) (← links)
• "Recycling" classical drugs for malaria (Q47887437) (← links)
• Docking and 3D-QSAR studies of BMS-806 analogs as HIV-1 gp120 entry inhibitors (Q47896531) (← links)
• Wound-Healing Peptides for Treatment of Chronic Diabetic Foot Ulcers and Other Infected Skin Injuries (Q48149164) (← links)
• PRIMACINS, N-cinnamoyl-primaquine conjugates, with improved liver-stage antimalarial activity (Q58768210) (← links)
• Synthesis, characterization and catalytic studies of bis(chloro)dioxomolybdenum(VI)-chiral diimine complexes (Q86340792) (← links)
• 2D and 3D QSAR studies of diarylpyrimidine HIV-1 reverse transcriptase inhibitors (Q62700164) (← links)
• Flexible computational docking studies of new aminoglycosides targeting RNA 16S bacterial ribosome site (Q62700181) (← links)
• Building on Surface-Active Ionic Liquids for the Rescuing of the Antimalarial Drug Chloroquine (Q98162911) (← links)
• "Clicking" an Ionic Liquid to a Potent Antimicrobial Peptide: On the Route towards Improved Stability (Q98783360) (← links)
• In Vitro Evaluation of Five Antimicrobial Peptides against the Plant Pathogen Erwinia amylovora (Q114342738) (← links)